Ayala Pharmaceuticals Inc
(ADXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 10-2022 | 10-2021 | 10-2020 | |
| Sales | 13 | 692 | 250 | 3,240 | 253 |
| Cost of Goods | 13 | 602 | N/A | N/A | N/A |
| Gross Profit | N/A | 90 | 250 | 3,240 | 253 |
| Operating Expenses | 36,279 | 38,195 | 19,560 | 22,026 | 26,702 |
| Operating Income | -36,266 | -37,503 | -19,310 | -18,786 | -26,449 |
| Other Income | -15,718 | 74 | 5,001 | 974 | 30 |
| Pre-tax Income | -51,984 | -37,429 | -14,309 | -17,812 | -26,419 |
| Income Tax | -3,912 | 584 | 50 | 50 | 50 |
| Net Income Continuous | -48,072 | -38,013 | -14,359 | -17,862 | -26,469 |
| Net Income | $-48,072 | $-38,013 | $-14,359 | $-17,862 | $-26,469 |
| EPS Basic Total Ops | -7.99 | -13.13 | -8.46 | -11.07 | -34.40 |
| EPS Basic Continuous Ops | -7.99 | -13.13 | -7.89 | -11.07 | -34.71 |
| EPS Diluted Total Ops | -7.99 | -13.13 | -8.46 | -11.07 | -34.40 |
| EPS Diluted Continuous Ops | -7.99 | -13.13 | -7.89 | -11.07 | -34.71 |
| EPS Diluted Before Non-Recurring Items | -7.99 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-35,897 | $-37,341 | $-18,837 | $-17,702 | $-23,827 |